规格

价格

库存

数量

25 mg

¥ 7,240

7日内发货

生物活性

产品描述	Daun02 is the topoisomerase inhibitor Daunorubicin prodrug.
体外活性	Daun02 is converted by β-galactosidase to Daunorubicin, which has been shown to reduce Ca2+-dependent action potentials in neuroblastoma cells [1]. Daun02 is a good substrate for β-galactosidase (β-gal) and it also is a topoisomerase inhibitor [2]. The concentration of Daun02 producing 50% (EC50) decrease in cell viability is 0.5 μM, 1.5 μM, and 3.5 μM for T47-D, Panc02, and MCF-7, respectively [3].
体内活性	Daun02 is a good substrate for β-gal (Km and Vmax: 0.37 mM; protein: 8.6 μmol/min/mg). Daun02 is 79% bound to plasma protein compares to 94% for Daunomycin, at a concentration of 10 μM [3].

化学信息

分子量	884.79
分子式	C₄₁H₄₄N₂O₂₀
CAS No.	290304-24-4
Smiles	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](NC(=O)OCc6ccc(O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)c(c6)[N+]([O-])=O)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O
密度	1.67 g/cm3 (Predicted)

储存&溶解度

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

实际储存温度请以COA为准

溶解度信息

DMSO: 100 mg/mL (113.02 mM), Sonication is recommended.

体内实验配方

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (3.73 mM), Sonication is recommended.

请按顺序添加溶剂，在添加下一种溶剂之前，尽可能使溶液澄清。如有必要，可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考，体内配方并不是绝对的，请根据不同情况进行调整。

溶液配制表

DMSO

该溶液配制表仅适用于固体产品。对于液体产品，请根据标明的浓度或密度计算稀释方案。

Daun02